Six Months Ended | ||
June 30, | ||
2016 | 2015 | |
Cash flows from operating activities: | ||
Net income attributable to Ebix, Inc. | $45,151 | $37,372 |
Net income attributable to noncontrolling interest | 243 | - |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 5,350 | 5,167 |
Benefit for deferred taxes | (6,635) | (6,014 ) |
Share based compensation | 1,332 | 839 |
Provision for doubtful accounts | 457 | 301 |
Debt discount amortization on promissory note payable | - | 8 |
Unrealized foreign exchange gain | (187) | (920) |
Amortization of capitalized software development costs | 654 | |
Reduction of acquisition earnout accruals | (511) | - |
Changes in assets and liabilities, net of effects from acquisitions: | ||
Accounts receivable | (6,065) | (3,662) |
Other assets | (2,417) | (2,606) |
Accounts payable and accrued expenses | (4,189) | (18,802) |
Accrued payroll and related benefits | (931) | 1,104 |
Deferred revenue | (1,136) | (2,036) |
Deferred rent | (83) | (125) |
Reserve for potential uncertain income tax return positions | 50 | 108 |
Liability - securities litigation settlement payment | - | (690) |
Other liabilities | (106) | 111 |
Net cash provided (used) by operating activities | 30,977 | 10,155 |
Cash flows from investing activities: | ||
Acquisition of Via Media Health, net of cash acquired | - | (1,000) |
Acquisition of P.B. Systems, net of cash acquired | - | (11,480) |
Capitalized software development costs | (694) | - |
Purchases of marketable securities | (994) | (704) |
Capital expenditures | (2,190) | (10,312) |
Net cash used in investing activities | (3,878) | (23,496) |
Cash flows from financing activities: | ||
Proceeds (repayments) from revolving line of credit, net | (87,427) | 30,000 |
Proceeds from term loan | 125,000 | - |
Repurchases of common stock | (37,657) | (34,481) |
Excess tax benefit from share-based compensation | - | 63 |
Proceeds from the exercise of stock options | 29 | 1,117 |
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested | (76) | (1,141) |
Dividend payments | (4,911) | (5,389) |
Principal payments of debt obligations | (600) | (623) |
Payments of capital lease obligations | - | (1) |
Net cash provided by (used in) financing activities | (5,642) | (10,455) |
Effect of foreign exchange rates on cash | (622) | (1,081) |
Net change in cash and cash equivalents | 20,835 | (24,877) |
Cash and cash equivalents at the beginning of the period | 57,179 | 52,300 |
Cash and cash equivalents at the end of the period | $78,014 | $27,423 |
Supplemental disclosures of cash flow information: | ||
Interest paid | $3,115 | $2,964 |
Income taxes paid | $10,869 | $20,926 |
Thank You for contacting us. Someone from the RCS team will be contacting you soon.
You are already subscribed for email alerts.
You may automatically receive Ebix, Inc.’s financial information by email. Please enter your contact details for email notifications below and click "Submit"
Link for this page has been sent to the recipient along with your message.
Thank you for visiting Ebix web site. To send this page link directly to a friend or colleague, complete the form below.
Copyright © 2022 Ebix Inc. Terms Of Use | Privacy Statement
This website is best viewed in ie9+, Firefox, Google Chrome, Opera and on all latest browsers.